AstraZeneca PLC (NASDAQ:AZN)
| 66.08 Delayed Data As of 4:00pm ET |  -0.125 / -0.19%Today’s Change | 52.65 Today|||52-Week Range 71.70 | +13.45% Year-to-Date |
Latest AZN News | Press Releases
Today’s Trading
| Previous close | 66.21 |
| Today’s open | 66.37 |
| Day’s range | 65.88 - 66.45 |
| Volume | 199,459 |
| Average volume (3 months) | 6,247,447 |
| Market cap | $205.2B |
Data as of 4:00pm ET, 11/29/2022
Growth & Valuation
| Earnings growth (last year) | -96.76% |
| Earnings growth (this year) | +25.46% |
| Earnings growth (next 5 years) | +13.75% |
| Revenue growth (last year) | +37.11% |
| P/E ratio | 103.4 |
| Price/Sales | 4.39 |
| Price/Book | 5.22 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVONovo Nordisk | +0.12 | +0.10% |
| NVSNovartis | -0.32 | -0.36% |
| BMYBristol-Myers Squibb | -0.16 | -0.20% |
| MRKMerck | +0.38 | +0.35% |
Data as of 4:00pm ET, 11/29/2022
Financials
| Next reporting date | February 2, 2023 |
| EPS forecast (this quarter) | $0.71 |
| Annual revenue (last year) | $37.8B |
| Annual profit (last year) | $112.0M |
| Net profit margin | 0.30% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Cambridgeshire |
Forecasts
